Clinical Trial Update: Use of 2-Octyl Cyanoacrylate (Dermabond) in Neonatal Circumcision: A Randomized Controlled Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating 2-Octyl Cyanoacrylate (Dermabond) for neonatal circumcision.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Redundant Prepuce

Drugs mentioned

• 2-Octyl cyanoacrylate (2-Octyl cyanoacrylate)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Redundant Prepuce | Phase 3 | Status: UNKNOWN